CDK ASSOCIATES, L.L.C.'s Net Worth
-$690 Thousand
Who is CDK ASSOCIATES, L.L.C.?
CDK ASSOCIATES, L.L.C. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Strongbridge Biopharma plc, Kala Pharmaceuticals, Inc., Molecular Templates, Inc., and Celator Pharmaceuticals Inc.
SEC CIK
CDK ASSOCIATES, L.L.C.'s CIK is 0001576081
Past Insider Trading and Trends
2018 was CDK ASSOCIATES, L.L.C.'s most active year for acquiring shares with 16 total transactions. CDK ASSOCIATES, L.L.C.'s most active month to acquire stocks was the month of June. 2017 was CDK ASSOCIATES, L.L.C.'s most active year for disposing of shares, totalling 2 transactions. CDK ASSOCIATES, L.L.C.'s most active month to dispose stocks was the month of June. 2019 saw CDK ASSOCIATES, L.L.C. paying a total of $3,750,000.00 for 468,750 shares, this is the most they've acquired in one year. In 2021 CDK ASSOCIATES, L.L.C. cashed out on 10,280,682 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Strongbridge Biopharma plc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -8.06M |
—
|
—
|
0
|
Oct 5
| |||
Form 4
| +22.48% | 1.48M |
$2.25 | $3,328,298.25 | 8.06M |
Sep 17 - Sep 18
| |||
Form 4
| +0.76% | 49.4K |
$3.99 | $197,131.71 | 6.58M |
Dec 26 - Dec 27
| |||
Form 4
| +3.77% | 237.08K |
$3.98 | $943,374.55 | 6.53M |
Dec 20 - Dec 21
| |||
Form 4
| +6.08% | 361K |
$4.93 | $1,778,514.07 | 6.29M |
Aug 8
| |||
Form 4
| +1.19% | 70K |
$4.66 | $326,466.00 | 5.93M |
Jul 30
| |||
Form 4
| +3.55% | 399.1K |
$4.83 | $1,923,180.69 | 11.63M |
Jul 24 - Jul 27
| |||
Form 4
| +1.03% | 55.5K |
$4.96 | $275,521.86 | 5.46M |
Jul 19 - Jul 23
| |||
Form 4
| +0.21% | 11.2K |
$4.97 | $55,629.28 | 5.41M |
Jul 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kala Pharmaceuticals, Inc. (KALA) Snapshot price: $7.1
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
∞
| 763.75K |
$15.00 |
—
| 763.75K |
Jul 20
| |||
Form 4/A
|
∞
| 763.75K |
$15.00 |
—
| 763.75K |
Jul 20
| |||
Form 4
|
∞
| 215K |
$15.00 | $3,225,000.00 | 215K |
Jul 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Molecular Templates, Inc. (MTEM) Snapshot price: $3.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +29.59% | 468.75K |
$8.00 | $3,750,000.00 | 2.05M |
Nov 21
| |||
Form 4
| +1.60% | 25K |
$3.45 | $86,250.00 | 1.58M |
Dec 26
| |||
Form 4
| +53.80% | 545.45K |
$5.50 | $2,999,997.00 | 1.56M |
Sep 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Celator Pharmaceuticals Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||